| Opioid | 2001 | 2013 | ||
|---|---|---|---|---|
| Use, no. (%) of women* | MEQ, % of total | Use, no. (%) of women* | MEQ, % of total | |
| Any opioid† | n = 937 | n = 1132 | ||
| Codeine | 922 (98.4) | 87.8 | 1069 (94.4) | 56.7 |
| Fentanyl | 0 (0) | - | S (< 1) | < 1.0 |
| Hydrocodone | S (< 1.0) | < 1.0 | 0 (0) | - |
| Hydromorphone | S (< 1.0) | < 1.0 | 11 (1.0) | 5.3 |
| Meperidine | 15 (1.6) | 4.3 | S (< 1.0) | < 1.0 |
| Morphine | S (< 1.0) | 6.6 | 26 (2.3) | 18.8 |
| Oxycodone | S (< 1.0) | < 1.0 | 49 (4.3) | 18.2 |
| Tramadol | 0 (0) | - | 29 (2.6) | < 1.0 |
Note: MEQ = morphine equivalents, S = suppressed data (for privacy reasons, data are suppressed for any count greater than 1 but less than 5).
*Percentages may sum to more than 100% because some patients had multiple opioids dispensed.
†Buprenorphine, butorphanol and dextropropoxyphene were included in the analysis, but had no counts.